Scapho Secukinumab 150 mg Injection
Secukinumab 150 mg Injection treats psoriatic arthritis, ankylosing spondylitis, and psoriasis.
In stock
Description
Secukinumab 150 mg Injection is employed for the treatment of diverse conditions, including psoriatic arthritis, ankylosing spondylitis, and psoriasis. It alleviates symptoms such as swelling, pain, and redness associated with these disorders, thereby enhancing physical function.
Administered by a healthcare professional, self-administration of Secukinumab 150 mg Injection is not recommended. It is advised to use it consistently at the same time daily to maximize its benefits. The patient should adhere to the prescribed regimen, continuing its use as directed by the doctor and completing the full course of treatment even if improvement is observed.
Additional information
Drug Composition | Secukinumab 150 mg Injection |
---|---|
Variant/Strength | 150 mg |
Dosage Form/Type | Injectables |
Product Benefits | Ankylosing spondylitis & Psoriasis, Treatment of Psoriatic arthritis |
Packaging | Vial |
Delivery Time | 7 – 15 Days, as per delivery location. |
Country of Origin | Made in India |
Reviews
Related Product
Lorem ipsum dolor sit amet consectetur. Id fames there aremany vulputate eget dolor.
Reviews
There are no reviews yet.